Former Microsoft and SomaLogic executives join senior leadership team of company developing platform for comprehensively…
Mean Baseline Adjusted Epinephrine Concentration over Time by Treatment, 0-2h Mean Baseline Adjusted Epinephrine Concentration…
The poster, featuring the phase 2 pharmacology study promising results, was selected and featured during…
Presentation evaluates the addition of D-PLEX₁₀₀ to the surgical site infection standard of care prophylaxis…
SYDNEY, Australia, April 12, 2022 (GLOBE NEWSWIRE) — Recce Pharmaceuticals Limited (ASX:RCE, FSE:R9Q), the Company…
— Canada’s Top Two Cannabis Market Leaders to Join Forces, Strengthening Operations and Unlocking up…
– Ampligen® (rintatolimod) has demonstrated promising activity as a potential maintenance therapy after systemic chemotherapy…
– Expansion will supply clinical grade cNeT for ongoing Phase I/IIa clinical trials and support…
TriTAC-XR demonstrates extended release mechanism that confirms accumulation of active drug which improves therapeutic index…
Presentations from multiple pipeline programs feature clinical and preclinical data demonstrating the unique biology of…
– First patient dosed in Phase 1/2 clinical trial in ABCC6 Deficiency – – Preliminary…
Miami, Florida, April 12, 2022 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (OTCQB: TOWTF) (CSE:…
Phase I/II trial initiation expected in 3Q 2022 SUNNYVALE, Calif., April 12, 2022 (GLOBE NEWSWIRE)…
Bridging Pharmacokinetics Study Autosomal Dominant Polycystic Kidney Disease – XRx-008 Program CALGARY, Alberta, April 12, 2022…
-New Preclinical Data Highlight Fadraciclib’s Apoptosis Enabling Mechanism in Leukemia- -Remarkable Synergy Observed with Venetoclax,…
PharmaTher to file ANDA and 505(b)(2) regulatory submissions with the FDA for novel uses, delivery…
Arecor Therapeutics plc(“Arecor” or the “Group”) ARECOR ANNOUNCES ORAL PRESENTATION AT ATTD 2022 OF PHASE…
Itziar Canamasas, Ph.D. ALX Oncology Appoints Itziar Canamasas, Ph.D., to its Board of Directors SOUTH…
CHATHAM, N.J., April 12, 2022 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a…
SHANGHAI, China, April 12, 2022 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a…